Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Net Current Assets

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Net Current Assets History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Net Current Assets (Including Current Investments) ₹2,317 Cr₹1,776 Cr₹1,819 Cr₹1,640 Cr₹1,619 Cr

What is the latest Net Current Assets ratio of NATCO PHARMA ?

The latest Net Current Assets ratio of NATCO PHARMA is ₹2,317 Cr based on Mar2023 Consolidated results.
Year Net Current Assets
Mar2023₹2,317 Cr
Mar2022₹1,776 Cr
Mar2021₹1,819 Cr
Mar2020₹1,640 Cr
Mar2019₹1,619 Cr

How is Net Current Assets of NATCO PHARMA Trending?

Years Net Current Assets % Change
Mar2023 ₹2,317 Cr
30.45
Mar2022 ₹1,776 Cr
-2.36
Mar2021 ₹1,819 Cr
10.91
Mar2020 ₹1,640 Cr
1.35
Mar2019 ₹1,619 Cr -

Compare Net Current Assets of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹18,107.0 Cr -1.1% 6.3% 78.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹364,315.0 Cr -0.1% -6.3% 53.5% Stock Analytics
CIPLA ₹114,614.0 Cr 1% -5% 53.3% Stock Analytics
DIVIS LABORATORIES ₹105,233.0 Cr 3.2% 15.3% 23.6% Stock Analytics
DR REDDYS LABORATORIES ₹104,900.0 Cr 1.1% 2.2% 26% Stock Analytics
ZYDUS LIFESCIENCES ₹99,426.0 Cr 3.9% -1.7% 85.2% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-1.1%

6.3%

78.3%

SENSEX

1%

2.2%

23.7%


You may also like the below Video Courses